Vanda Pharmaceuticals (VNDA) Net Cash Flow (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Net Cash Flow of -$30.8 million in Q1 2026, down 307.71% quarter-over-quarter from $14.8 million in Q4 2025, and down 426.16% year-over-year from $9.4 million in Q1 2025.
Vanda Pharmaceuticals' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$30.8 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 426.16% year-over-year to -$30.8 million; the TTM figure through Mar 2026 stood at -$57.7 million (down 334.92% YoY), while the FY2025 annual figure was -$17.5 million, up 47.55% from the prior year.
- Net Cash Flow came in at -$30.8 million for Q1 2026 at Vanda Pharmaceuticals, down from $14.8 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $219.1 million in Q1 2023 to a low of -$204.1 million in Q2 2023.
- A 5-year average of $105764.7 and a median of -$8.8 million in 2022 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow jumped 5078.73% in 2022 and tumbled 2224.23% in 2023, its largest moves.
- Vanda Pharmaceuticals' Net Cash Flow stood at $85.4 million in 2022, then sank by 155.61% to -$47.5 million in 2023, then jumped by 104.25% to $2.0 million in 2024, then soared by 632.76% to $14.8 million in 2025, then sank by 307.71% to -$30.8 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$30.8 million, $14.8 million, and -$10.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -30.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.76 Mn |
| Mar 31, 2026 | -30.76 Mn |
| Dec 31, 2025 | 14.81 Mn |
| Dec 31, 2025 | 14.81 Mn |
| Sep 30, 2025 | -10.78 Mn |
| Sep 30, 2025 | -10.78 Mn |
| Jun 30, 2025 | -30.95 Mn |
| Jun 30, 2025 | -30.95 Mn |
| Mar 31, 2025 | 9.43 Mn |
| Mar 31, 2025 | 9.43 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | -2.52 Mn |
| Sep 30, 2024 | -2.52 Mn |
| Jun 30, 2024 | -22.19 Mn |
| Jun 30, 2024 | -22.19 Mn |
| Mar 31, 2024 | -10.65 Mn |
| Mar 31, 2024 | -10.65 Mn |
| Dec 31, 2023 | -47.52 Mn |
| Dec 31, 2023 | -47.52 Mn |
| Sep 30, 2023 | 33.28 Mn |
| Sep 30, 2023 | 33.28 Mn |
| Jun 30, 2023 | -204.11 Mn |
| Jun 30, 2023 | -204.11 Mn |
| Mar 31, 2023 | 219.10 Mn |
| Mar 31, 2023 | 219.10 Mn |
| Dec 31, 2022 | 85.45 Mn |
| Dec 31, 2022 | 85.45 Mn |
| Sep 30, 2022 | -8.94 Mn |
| Sep 30, 2022 | -8.94 Mn |
| Jun 30, 2022 | -8.78 Mn |
| Jun 30, 2022 | -8.78 Mn |
| Mar 31, 2022 | 14.91 Mn |
| Mar 31, 2022 | 14.91 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | -6.82 Mn |
| Sep 30, 2021 | -6.82 Mn |
| Jun 30, 2021 | -14.88 Mn |
| Jun 30, 2021 | -14.88 Mn |
| Mar 31, 2021 | 11.11 Mn |
| Mar 31, 2021 | 11.11 Mn |
| Dec 31, 2020 | 4.05 Mn |
| Dec 31, 2020 | 4.05 Mn |
| Sep 30, 2020 | -38.35 Mn |
| Sep 30, 2020 | -38.35 Mn |
| Jun 30, 2020 | 30.34 Mn |
| Jun 30, 2020 | 30.34 Mn |
| Mar 31, 2020 | 19.87 Mn |
| Mar 31, 2020 | 19.87 Mn |
| Dec 31, 2019 | 5.68 Mn |
| Dec 31, 2019 | 5.68 Mn |
| Sep 30, 2019 | -7.32 Mn |
| Sep 30, 2019 | -7.32 Mn |
| Jun 30, 2019 | 12.17 Mn |
| Jun 30, 2019 | 12.17 Mn |
| Mar 31, 2019 | -26.63 Mn |
| Mar 31, 2019 | -26.63 Mn |
| Dec 31, 2018 | 251,000.00 |
| Dec 31, 2018 | 251,000.00 |
| Sep 30, 2018 | -99,000.00 |
| Sep 30, 2018 | -99,000.00 |
| Jun 30, 2018 | -94.38 Mn |
| Jun 30, 2018 | -94.38 Mn |
| Mar 31, 2018 | 121.68 Mn |
| Mar 31, 2018 | 121.68 Mn |
| Dec 31, 2017 | 10.91 Mn |
| Dec 31, 2017 | 10.91 Mn |
| Sep 30, 2017 | 8.34 Mn |
| Sep 30, 2017 | 8.34 Mn |
| Jun 30, 2017 | -5.90 Mn |
| Jun 30, 2017 | -5.90 Mn |
| Mar 31, 2017 | -20.32 Mn |
| Mar 31, 2017 | -20.32 Mn |
| Dec 31, 2016 | 7.70 Mn |
| Dec 31, 2016 | 7.70 Mn |
| Sep 30, 2016 | 9.57 Mn |
| Sep 30, 2016 | 9.57 Mn |
| Jun 30, 2016 | -15.55 Mn |
| Jun 30, 2016 | -15.55 Mn |
| Mar 31, 2016 | -12.10 Mn |
| Mar 31, 2016 | -12.10 Mn |
| Dec 31, 2015 | 4.06 Mn |
| Dec 31, 2015 | 4.06 Mn |
| Sep 30, 2015 | -1.55 Mn |
| Sep 30, 2015 | -1.55 Mn |
| Jun 30, 2015 | 15.53 Mn |
| Jun 30, 2015 | 15.53 Mn |
| Mar 31, 2015 | -28.09 Mn |
| Mar 31, 2015 | -28.09 Mn |
| Dec 31, 2014 | 45.59 Mn |
| Dec 31, 2014 | 45.59 Mn |
| Sep 30, 2014 | -1.69 Mn |
| Sep 30, 2014 | -1.69 Mn |
| Jun 30, 2014 | -26.27 Mn |
| Jun 30, 2014 | -26.27 Mn |
| Mar 31, 2014 | -21.50 Mn |
| Mar 31, 2014 | -21.50 Mn |
| Dec 31, 2013 | -77.41 Mn |
| Dec 31, 2013 | -77.41 Mn |
| Sep 30, 2013 | 38.54 Mn |
| Sep 30, 2013 | 38.54 Mn |
| Jun 30, 2013 | -6.30 Mn |
| Jun 30, 2013 | -6.30 Mn |
| Mar 31, 2013 | 21.16 Mn |
| Mar 31, 2013 | 21.16 Mn |
| Dec 31, 2012 | -15.76 Mn |
| Dec 31, 2012 | -15.76 Mn |
| Sep 30, 2012 | 10.13 Mn |
| Sep 30, 2012 | 10.13 Mn |
| Jun 30, 2012 | -13.71 Mn |
| Jun 30, 2012 | -13.71 Mn |
| Mar 31, 2012 | 20.17 Mn |
| Mar 31, 2012 | 20.17 Mn |
| Dec 31, 2011 | 27.60 Mn |
| Dec 31, 2011 | 27.60 Mn |
| Sep 30, 2011 | 9.94 Mn |
| Sep 30, 2011 | 9.94 Mn |
| Jun 30, 2011 | -2.13 Mn |
| Jun 30, 2011 | -2.13 Mn |
| Mar 31, 2011 | 9.96 Mn |
| Mar 31, 2011 | 9.96 Mn |
| Dec 31, 2010 | -59.91 Mn |
| Dec 31, 2010 | -59.91 Mn |
| Sep 30, 2010 | -43.18 Mn |
| Sep 30, 2010 | -43.18 Mn |